Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

Many aging men will experience both erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), resulting in lower urinary tract symptoms (LUTS). Basic and clinical evidence suggests common pathogenic mechanisms underlying both LUTS and ED. Decreases in the nitric oxide-cyclic guanosine monoph...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Elterman, Dean S, Chughtai, Bilal, Lee, Richard K, Te, Alexis E, Kaplan, Steven A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MedReviews, LLC 2012
Gaiak:
Treatment Update
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602730/
https://ncbi.nlm.nih.gov/pubmed/23526698
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak